- Home
- CRBP vs EPSM Comparison
CRBP vs EPSM Comparison
Compare CRBP & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- EPSM
- Stock Information
- Founded
- CRBP 2009
- EPSM 2010
- Country
- CRBP United States
- EPSM China
- Employees
- CRBP N/A
- EPSM N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- EPSM
- Sector
- CRBP Health Care
- EPSM
- Exchange
- CRBP Nasdaq
- EPSM Nasdaq
- Market Cap
- CRBP 210.8M
- EPSM 178.3M
- IPO Year
- CRBP N/A
- EPSM 2025
- Fundamental
- Price
- CRBP $11.23
- EPSM $3.84
- Analyst Decision
- CRBP Strong Buy
- EPSM
- Analyst Count
- CRBP 9
- EPSM 0
- Target Price
- CRBP $48.38
- EPSM N/A
- AVG Volume (30 Days)
- CRBP 546.2K
- EPSM 3.7M
- Earning Date
- CRBP 11-12-2025
- EPSM 12-16-2025
- Dividend Yield
- CRBP N/A
- EPSM N/A
- EPS Growth
- CRBP N/A
- EPSM N/A
- EPS
- CRBP N/A
- EPSM 0.02
- Revenue
- CRBP N/A
- EPSM $12,518,070.00
- Revenue This Year
- CRBP N/A
- EPSM N/A
- Revenue Next Year
- CRBP $220.00
- EPSM N/A
- P/E Ratio
- CRBP N/A
- EPSM $183.38
- Revenue Growth
- CRBP N/A
- EPSM N/A
- 52 Week Low
- CRBP $4.64
- EPSM $1.31
- 52 Week High
- CRBP $20.56
- EPSM $155.00
- Technical
- Relative Strength Index (RSI)
- CRBP 38.90
- EPSM N/A
- Support Level
- CRBP $10.88
- EPSM N/A
- Resistance Level
- CRBP $12.43
- EPSM N/A
- Average True Range (ATR)
- CRBP 0.76
- EPSM 0.00
- MACD
- CRBP 0.05
- EPSM 0.00
- Stochastic Oscillator
- CRBP 51.59
- EPSM 0.00
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.